Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

In Silico Design of a Chimeric Humanized L-Asparaginase.

Version 1 : Received: 23 January 2023 / Approved: 30 January 2023 / Online: 30 January 2023 (03:21:51 CET)

A peer-reviewed article of this Preprint also exists.

Pedroso, A.; Herrera Belén, L.; Beltrán, J.F.; Castillo, R.L.; Pessoa, A.; Pedroso, E.; Farías, J.G. In Silico Design of a Chimeric Humanized L-asparaginase. Int. J. Mol. Sci. 2023, 24, 7550. Pedroso, A.; Herrera Belén, L.; Beltrán, J.F.; Castillo, R.L.; Pessoa, A.; Pedroso, E.; Farías, J.G. In Silico Design of a Chimeric Humanized L-asparaginase. Int. J. Mol. Sci. 2023, 24, 7550.

Abstract

Acute lymphoblastic leukemia (ALL) is the most common cancer among children worldwide, characterized by an overproduction of undifferentiated lymphoblasts in the bone marrow. The treatment of choice for this disease is the enzyme L-asparaginase (ASNase) from bacterial sources. ASNase hydrolyzes circulating L-asparagine in plasma, leading to starvation of leukemic cells. The ASNase formulations of E. coli and E. chrysanthemi present notorious adverse effects, especially the immunogenicity they generate, which undermines both their effectiveness as drugs and patient safety. In this study, we developed a humanized chimeric enzyme from E. coli L-asparaginase, which would reduce the immunological problems associated with current L-asparaginase therapy. For these, the immunogenic epitopes of E. coli L-asparaginase (PDB: 3ECA) were determined and replaced with those of the less immunogenic Homo sapiens asparaginase (PDB:4O0H). The structures were modeled using the Pymol software and the chimeric enzyme was modeled using the SWISS MODEL service. A humanized chimeric enzyme with four subunits similar to the template structure was obtained, and the presence of asparaginase enzymatic activity was predicted by protein-ligand docking.

Keywords

L-asparaginase; chimeric; in silico; immunogenicity; acute lymphoblastic leukemia

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.